Page 151 – Vaccine development: a challenging enterprise

Professor Stephen C Inglis

References

1. Waye A, Jacobs P, Schryvers AB. Vaccine development costs: a review. Exp Rev Vaccines 2013;12:1495–1501.
2. Hall AJ. The United Kingdom Joint Committee of Vaccination and Immunisation. Vaccine 2010;A54–A57.
3. Reed SG. Vaccine adjuvants. Exp Rev Vaccines 2013;12:705–706.
4. Department of Health and Social Care. Open consultation: cost effectiveness methodology for vaccination programmes. Published 26 February 2018. Available at: https://www.gov.uk/government/consultations/cost-effectiveness-methodology-for-vaccination-programmes
5. The UK Vaccine R&D Network. Vaccine Development Process Map. Available at: www.vaccinedevelopment.org.uk